Avantguardinc
1 known investors
AvantGuard develops Avantamine, an antimicrobial molecule designed to eliminate bacteria, viruses, and fungi on surfaces and skin without generating resistance, including a topical treatment targeting the drug-resistant fungal pathogen Candida auris. Its technology can be formulated as an antiseptic, disinfectant, surface coating, or plastics additive, aimed at healthcare settings and infection control.</parameter> <parameter name="founders">[]
BiotechHealthtechNew Materials